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Summary
Background: The economic burden of TB in India is enormous as TB perpetuates and exacerbates poverty. Revised National
Tuberculosis Control Programme (RNTCP) based on DOTS strategy is currently being implemented in India.  The purpose
of this study is to estimate the costs incurred by tuberculosis patients treated under RNTCP in a district in Tamilnadu where
services are decentralized for diagnosis and treatment.
Method: In all, 455 patients registered under RNTCP between June and December 2000, in Tiruvallur district were
interviewed to collect the following information: Demographic, socio-economic characteristics of patients, expenditure
incurred due to illness and effect of illness on employment. Based on the data collected, various costs (direct medical, non-
medical, indirect and total costs incurred on account of tuberculosis before and during treatment) were estimated. In addition
Standard of Living Index (SLI) was calculated for patients.
Results: Of 455 patients, 62% had low SLI. The median direct, indirect and total costs for 343 patients who successfully
completed treatment were as follows: pre treatment direct costs were Rs 340, during treatment direct costs Rs 100; more
than 50% of patients did not incur any indirect costs in both pre treatment and during treatment periods and overall total
costs were Rs 1398. About 12% of patients lost more than 60 workdays and after completing treatment, 88% returned to
work.
Conclusion: For patients registered under RNTCP in Tiruvallur district in Tamilnadu, the findings that the total patient
costs were Rs 1398/- and also the patients returned to work early establishes the economic benefits to patients treated under
DOTS and lend support to rapid expansion of DOTS programme, particularly in low-income countries.
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BACKGROUND
Worldwide, tuberculosis affects the most
productive age group1. On an average, 3-4 months
of work time are lost if an adult has tuberculosis,
resulting in a loss of about 20-30% of annual
household income2. An average of 15 years of income
is lost if an individual dies of the disease. Thus,
tuberculosis causes enormous social and economic
disruption and hampers the development of the
country3. Besides, projections from our earlier
studies conducted prior to the implementation of
Revised National Tuberculosis Control Programme
(RNTCP) in south India indicate that despite being
offered free diagnosis and treatment by government,
the projected out of pocket expenditure incurred by
tuberculosis patients annually was more than US$ 3
billion4.
 Directly Observed Treatment Short course
(DOTS) strategy is one of the largest public health
programmes found to be beneficial in the world. This
strategy has been successful in reducing death rates
and increasing cure rates in India4,5. Since evidence
supporting this has mainly come from cost effective
analysis (excluding patient costs) against historical
controls6-12, there is a need to carry out studies on
patient costs13. One of the key components of
RNTCP (DOTS) is that each dose of anti–
tuberculosis drugs should be administered to patients
under the supervision of a DOT provider, either from
the community or the health system. The selection
of DOT centre is according to patient’s convenience
(closer to patient’s residence), so that patients do
not lose wages or incur transportation charges for
treatment in the programme14.
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Earlier studies had shown that patients quite
often ‘shop around’ for diagnosis before they were
started on treatment under programme2. The health
care delivery system in India consists of a complex
arrangement of government, private and non-
governmental organisation (NGO) centres. It was
observed that 48% of patients with chest symptoms
in rural areas had preferred private health care facilities
first. Socio-economic factors such as literacy and
family income significantly influenced the care-
seeking behaviour and patients switched from private
to government providers, invariably due to financial
constraints15.
Therefore, we undertook a study to estimate
the direct, indirect and total (diagnosis and treatment)
costs to patients on account of tuberculosis treated
in DOTS programme in Tiruvallur district of
Tamilnadu. In this paper, we present the results of
our study estimating the various costs incurred by
patients on account of TB.
METHOD
RNTCP (DOTS programme)
In RNTCP, diagnosis is primarily by sputum
microscopy, treatment is directly observed with
standardized regimens (3 categories), and uniform
recording and reporting systems are used. Diagnosis
and treatment are free of cost to the patients14, 16.
Study area and study population
This study was conducted in Velliyur TB
unit of Tiruvallur district (5,80,000 rural population),
of Tamilnadu. The main occupation was agriculture.
Patients registered between July and December 2000
formed the study population.
Data collection
A semi–structured and pre–tested (used
previously)2 schedule was used for data collection
and patients were interviewed at two time–points:
one at the end of intensive phase of treatment and
the second on completion of treatment. Trained field
investigators conducted the interviews after obtaining
informed consent at the patient’s residence.
The data collected during the first interview
were demographic, socio economic, employment,
assets of the patient and family. Expenditure incurred
due to illness, effect of illness on employment
(workdays lost and loss of income) from onset of
symptoms to diagnosis and during treatment up to
IP based on 3 months recall memory. During the
second interview, data was collected on expenditure
incurred due to illness, effect of illness on
employment, and workdays lost during their illness
(during CP up to end of treatment)
During the interviews, information collected
was cross–checked with patients’ prescription slips
and hospital discharge summaries wherever
available. Indirect costs were calculated only for
employed patients and not for unemployed patients
since the time lost on account of non-labour activities
is difficult to assess in financial terms. Based on the
data collected, various costs (direct, indirect, medical,
non-medical and total) and standard of living index
(SLI) were calculated for all patients.
Costs assessed
Direct costs
Consultation fees and money spent on
investigations and drugs were classified as medical
expenditure. Money spent on travel, lodging, special
food and expenditure incurred for persons
accompanying the patient were classified as non-
medical expenditure.
Indirect costs
Indirect costs were classified as loss of
wages due to illness, decreased earning ability due
to illness, or long term disability that necessitated
change in type of work.
Total cost
Total cost includes the expenditure incurred
pre treatment and during treatment under direct and
indirect costs. The cost was calculated in terms of
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Indian rupees and US dollars (exchange rate during
study period the study: $1 US= Rs. 45).
Total treatment cost was calculated for only
those patients who completed treatment successfully.
Patients with treatment outcomes such as defaulted,
migrated, transferred out and died were not available
and hence excluded. Patients who had failed and were
on re-treatment were not considered for this analysis.
Data was also collected on money borrowed
on account of illness from all patients.
Assessment of Standard of Living Index (SLI)
SLI was calculated based on the definitions used
in the National Family Health Survey (NFHS-I)15.
The factors considered were type of house,
availability and type of toilet facility, main fuel used
for cooking, source of drinking water, availability of
separate room for cooking, ownership of house,
ownership of land, ownership of livestock and
ownership of other durable goods. Scoring system
was used to classify the patients into 3 groups (scores
0-14 for a low SLI, 15-24 for a medium SLI and
25-67 for a high SLI).
Data Management and statistical methods used
To ensure accuracy, two independent data
entry operators keyed all records twice. Data were
checked for errors and analysed using the SPSS. In
univariate analysis, categorical variables were
compared. As the distribution of costs was positively
skewed, median costs were used.
RESULTS
Study population
During the study period, 467 tuberculosis
patients were registered and 97% (455) were
interviewed first at the end of IP (12 could not be
interviewed; because of inadequate addresses or
migration). Attempts were made to visit all these
patients at the end of treatment; 343 had completed
treatment, 69 defaulted; 9 failed to treatment and 26
died. Hence the treatment cost analysis was done
only for those who had successfully completed
treatment.
Profile of the study population
The demographic and socio-economic
characteristics (age, sex, family size, education,
occupation and low SLI) of the study population are
described in Table 1. The female patients formed
one fourth of the study population. The median age
Table 1: Demographic and socio-economic
characteristics of patients on RNTCP
south India from 2000
COSTS  OF  TB  TREATMENT  UNDER  DOTS
 Number % 
Age (years) 
       15–54 
       55+ 
 
324 
131 
 
71 
29 
Sex 
       Male 
 
331 
 
73 
Family size 
       4+ 
 
295 
 
65 
Education 
      Illiterate 
 
197 
 
43 
Occupation 
     Employed 
     Unemployed* 
 
358 
97 
 
79 
21 
@Poverty 
     Below poverty line 
 
281 
 
62 
Standard of living 
Index 
      Low 
      Medium 
      High 
 
 
296 
140 
  19 
 
 
62 
33 
 5 
Total patients 455 100 
Patients who could read and write were considered as literate in  
this study. 
*Unemployed, student, retired, housewife 
@Poverty line:31 per capita income per month <Rs 335.46  
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was 45 years and 62% of the patients belonged to
low SLI or below poverty line.
Costs assessment
Figure 1 gives the various costs estimated
and also the population studied for estimation of costs.
Direct cost: pretreatment direct cost was calculated
for all patients (n = 455) and during treatment direct
cost was calculated for those who had completed
treatment (n = 343). Indirect cost: pretreatment
indirect cost was calculated only for all employed
patients (n = 358) and during treatment indirect cost
was calculated for those who had completed
treatment and employed (n = 271). Total cost: which
includes direct (pre and during treatment) and indirect
(pre and during treatment) (n = 271).
Pre treatment cost (Rs) During treatment cost (Rs)  
Direct Indirect Total Direct Indirect Total 
Mean 
Median 
Range 
Number 
874 
340 
0–15710 
455 
951 
0 
0–27375 
358 
1762 
600 
0–30360 
358 
227 
100 
0–2000 
343 
825 
0 
0–13100 
271 
1014 
316 
0–13712 
271 
Indirect and total costs were calculated for only employed patients 
 
Table 2: Costs (direct, indirect and total) incurred by TB patients registered under RNTCP
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Total patients interviewed (n=455) 
During treatment cost 
For patients who completed 
treatment (n=343) 
Pre treatment cost assessed for all 
patients including employed 
patients (n=455) 
Direct cost for all patients (n=455) 
Indirect cost for employed  (n=358) 
Total cost (direct and indirect) for 
patients who completed treatment 
and employed (n=271) 
Direct cost for patients who 
completed treatment (n=343) 
 
Indirect cost only for employed 
patients who completed treatment 
(n=271) 
Total patients registered (n=467) 
Figure 1: Study population for costs assessment
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Direct costs
For patients registered under the programme,
the median pre-treatment direct cost was Rs 340
and the median direct cost during treatment was Rs
100 (Table 2).
Pre-treatment cost (Medical and non-medical)
Medical: The median pre–treatment direct
medical cost for doctor’s consultation was Rs 10
(range Rs 0–5500) and no expenditure for
investigations and medicines in more than 50% of
patients  (range 0-4000).
Non-Medical: The median direct non–
medical cost for travel was Rs 34 (range Rs 0–1932).
More than half the patients did not incur any cost
either for accommodation (range Rs 0–4200) or for
special food (range Rs 0–1200).
During treatment cost
None of the patients incurred any medical
cost during treatment. More than half the patients
did not incur costs for transportation (range Rs 0–
372) during treatment. The median cost of special
food was Rs 100 (range Rs 0–2000).
Indirect costs
Indirect cost was calculated for 358
employed patients at the time of first interview and
271 employed patients at the time of second interview.
Pre–treatment indirect cost was nil in 59% of
patients. During treatment, the indirect cost was nil
in more than 50% of patients (Rs 0–13,100) (Table
2).
Workdays lost during treatment
Fifty four percent of working patients did
not lose workdays on account of illness. It was
observed that 26% of patients lost less than 30 days
of work. During treatment total workdays lost
exceeded 60 days in 12% of patients. (Figure 2) At
the end of treatment, 88% of patients returned to
work.
Total costs
Pre–treatment total costs (direct and
indirect) was Rs 600, costs during treatment was
54
26
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%
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n
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Figure 2: Proportion of tuberculosis patients in relation to loss of workdays during treatment
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Rs 316 and total cost to patients was Rs 1398 (US$
30).
Table 3 compares direct, indirect and total
costs. The direct cost was more than Rs 1000 in
31%, indirect cost was more than Rs 1000 in 34%
of patients and the total cost was more than Rs 3000
in 29% of patients.
Figure 3 compares the overall total costs
for male (Rs 788) and female (Rs 1243) patients.
Proportion of total cost in relation to annual
family income
The proportion of total cost in relation to
annual family income was computed for all patients.
Among patients whose income was below the
poverty line, this proportion was 19% and among
patients whose income was above the poverty line,
it was 10% respectively (Fig. 4).
Debts incurred on account of illness
Of the total of 455 patients, 324 (71%) had
borrowed money on account of TB and 50% of
patients had borrowed more than Rs 2000 to meet
their expenses.
DISCUSSION
This study has assessed the potential
economic benefits of DOTS to patients treated under
RNTCP in rural areas. The total cost for patients,
from the onset of symptoms till completion of
treatment, was Rs 1398 in DOTS programme. This
is a saving of Rs 4588 to patients when compared
with an earlier study of pre-RNTCP era2. If it is
extrapolated to the whole country, for the estimated
14 million cases, the saving will be about 434 million
US$. These results strongly suggest that DOTS
programme is cost saving for patients and thus lends
support for advocacy for universal DOTS in India.
One of the goals of RNTCP is that patient
Table 3: Distribution of patients according to rupees spent for TB
Figure 3: Comparison of total costs incurred by female and male tuberculosis patients
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Cost (in Rs) Direct Indirect Total 
 No % No % No % 
<1000 
1001–2000 
2001–3000 
>3000 
186 
46 
20 
19 
69 
17 
7 
7 
178 
26 
25 
42 
66 
10 
9 
15 
117 
45 
31 
78 
43 
17 
11 
29 
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should not lose wages or incur expenditure for travel.
Extra efforts were, therefore, made to provide
decentralized services for diagnosis and treatment
closer to patient’s residence14. Our findings confirm
that travel costs for treatment were definitely lower.
This refutes the findings reported earlier that patients
taking DOT might incur increased costs17. The
DOTS patients had the advantage of uninterrupted
drug supply since their drugs for the entire period
were available in a box. In addition, treatment was
given under supervision with prompt defaulter
retrieval action. This had resulted in good treatment
outcomes compared to treatment outcomes in the
era prior to RNTCP18.
The DOTS patients reported significantly
lower indirect costs (work absenteeism) compared
to our previous study (done in pre-DOTS era)
Rs.1776 vs Rs 3934. The loss of workdays exceeding
60 was observed in 12% of patients and this
observation is contrary to that observed in Zambia
(31%)19. This could be probably due to provision of
decentralized diagnostic and treatment services. This
study provides evidence that DOTS strategy is helping
patients to return to work early. In our series, as
54% of patients did not lose workdays on account
of illness, this will contribute to the overall economic
and social development of the country and in
alleviation of poverty.
In the current series, the direct pre-
treatment cost incurred by DOTS patients was Rs
300; this was much less compared to the pre-
treatment direct cost incurred by patients in a rural
area which was Rs 5502. Similar observations have
been reported by others20-21. The total pre–treatment
cost was higher compared to total during treatment
cost. This implies that patients spent considerable
time shopping for diagnosis, probably due to lack of
awareness on TB and free services. Similar findings
like majority of patients making 3 or more visits to
private practitioners for TB diagnosis, thus depleting
financial resources have been reported earlier22-23. It
was observed that patients spent more when they
first consulted a private practitioner than a
government provider (Rs 446/, Rs 151/)24. These
findings emphasize the importance of educating the
community on TB and on availability of free services.
Building partnerships with the private sector is a must
for reducing the expenditure on “shopping” for
diagnosis.
The direct costs among female patients, in
our series, were observed to be higher than among
males. Similar findings were reported earlier25. This
observation was probably due to the fact that women
patients aged more than 45 years found treatment
services less convenient for taking DOT as they quite
often needed someone to accompany them to go to
DOT centre26. In India, the parents of young women
of marriageable age also find it a problem either to
COSTS  OF  TB  TREATMENT  UNDER  DOTS
Below poverty line
19%
Abov e poverty  line
10%
 
 
Poverty line: Rs. < 335.46 per capita per month 31
Figure 4. Proportion of total costs incurred on account of TB in relation to annual family income
among patients with income below and above the poverty line
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reveal the diagnosis or to send them to a nearby DOT
centre27. This finding reinforces the need to organize
special support groups in the community for
tuberculosis patients, especially for female patients.
In this series, nearly two thirds of the
patients registered under programme had low
SLI (poor socio economic strata). In our series,
19% of annual income was spent on TB by
patients below poverty line. This finding is in
conformity with a report from Thailand28 which had
shown that patients below the poverty line spent more
than 15% of the annual income on TB resulting in
further impoverishment and, hence, provides
compelling justification for the rapid expansion of
DOTS, especially in low–income countries.  This
finding also draws attention to the contribution
tuberculosis control makes to alleviation of poverty
by reducing the economic burden that the disease
inflicts on the poor29-30.
CONCLUSION
For the first time, this paper on economic
evaluation of DOTS strategy, confirms that the
DOTS strategy saved costs, achieved effective
cure, saved lives, reduced disability and
decreased work absenteeism for TB patients,
especially among the poor, enabling them to
return to work at the earliest, thus increasing
their productivity. This information is vital for
programme managers, health administrators,
potential donors and policy–makers for
promoting the DOTS strategy.
Limitations of the study
Since the findings of this study are based
on interview of patients, it is likely that patients had
difficulty in recalling information regarding expenses
incurred a few months ago. We tried to minimize
bias in patients recall by interviewing 90% of the
patients within two months from the date of
registration. The study included patients who were
being treated as outpatients at rural government health
facilities, and not hospitalized patients or those
seeking treatment for tuberculosis from the private
sector. Therefore, the estimated costs in this study
may be lower than the actual costs.
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